Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers

Juliet E Wolford1, Erin Ferrigni1, Daniel Margul1

  • 1Division of Gynecologic Oncology, University of Cincinnati, Cincinnati, OH, USA.

Abstract

Insights

Precision medicine offers targeted therapies for advanced gynecologic cancers like ovarian, endometrial, and cervical cancers. Identifying robust biomarkers is crucial for future treatment advancements and approvals.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Advanced gynecologic malignancies present significant treatment challenges.
  • Genomic advancements are driving the development of individualized therapeutic strategies.

Purpose of the Study:

  • To review current trends in precision medicine for gynecologic cancer treatment.
  • To highlight the role of molecular aberrations in identifying targetable mutations.

Main Methods:

  • Review of current literature on precision medicine in gynecologic oncology.
  • Identification of molecular targets and therapeutic agents.

Main Results:

  • Targetable mutations in ovarian, endometrial, and cervical cancers include hormonal therapies, anti-angiogenic agents, poly-ADP-ribose polymerase inhibitors (PARPi), and immunotherapy.
  • Novel targeted agents are rapidly entering clinical trials, leading to new approvals.
  • Challenges remain in universal precision medicine implementation.

Conclusions:

  • Precision medicine, utilizing targeted therapies, is transforming gynecologic cancer treatment.
  • Further research is needed to identify and validate predictive biomarkers for optimal patient selection.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K